ClinicalTrials.Veeva

Menu

Assessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Nigerian Women

Unilever logo

Unilever

Status

Completed

Conditions

Iron Deficiency Anemia

Treatments

Other: Meals prepared with iron fortified cube with High stabilizer level
Other: Meals prepared with iron fortified cube with Medium stabilizer level
Other: Meals prepared with iron fortified cube with Low stabilizer level

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02815449
FDS-SAV-2103

Details and patient eligibility

About

The prevalence of iron deficiency anemia is a wide spread problem in Africa and iron fortification can be an effective strategy to decrease this.

In the current study adding different levels of a stabilizer to iron fortified cubes and it's effect on iron bioavailability from these cubes will be studied in the context of a Nigerian meal in women.

24 Female subjects with low serum ferritin levels will be included in the study. The study will last 64 days and subjects will be asked to consume a breakfast and lunch prepared with a bouillon cube with isotope labeled iron during 3 periods of 5 consecutive days. The absorption of iron will be evaluated after every period and compared between the cubes.

Enrollment

24 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy female Nigerian subjects;
  • Age > 18 and <40 years at screening;
  • Body weight <65 kg;
  • Apparently healthy: no medical conditions which might affect study measurements (judged by study physician);
  • With iron deficiency judged by a serum ferritin concentration of <15µg/L;
  • Reported intense sporting activities ≤ 10h/w;
  • Reported alcohol consumption ≤ 14 units/w;
  • Willing and able to participate in the study;
  • Having given a written informed consent.

Exclusion criteria

  • Being an employee of Unilever or the Department of Family, Nutrition and Consumer Science of the Obafemi Alowolo University;
  • Blood donation or significant blood loss over the past 6 months;
  • Being severely anemic (hemoglobin < 8.0 g/dL)
  • Reported use of any medically- or self-prescribed diet;
  • Use of vitamin or mineral supplements and unwillingness to discontinue their use one week prior the study and during the study;
  • Smoking or consuming tobacco in any form, and/or was smoking or consuming tobacco in any form for 6 months preceding the study and/or will be smoking or consuming tobacco in any form, during the study;
  • Is pregnant or will be planning pregnancy during the study period;
  • Is lactating or has been lactating in the 6 weeks before pre-study investigation and/or during the study period;
  • Known gastrointestinal (including helminth infection) or metabolic disorders;
  • Participation in another clinical trial during the last 30 days prior to the beginning of the study;
  • Symptomatic malaria (no blood smear analyses on malaria required)

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

24 participants in 3 patient groups

Low stabilizer level
Experimental group
Description:
Meals prepared with iron fortified cube with low stabilizer level
Treatment:
Other: Meals prepared with iron fortified cube with Low stabilizer level
Medium stabilizer level
Experimental group
Description:
Meals prepared with iron fortified cube with medium stabilizer level
Treatment:
Other: Meals prepared with iron fortified cube with Medium stabilizer level
High stabilizer level
Experimental group
Description:
Meals prepared with iron fortified cube with high stabilizer level
Treatment:
Other: Meals prepared with iron fortified cube with High stabilizer level

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems